Correction to: Cell Death and Differentiation (2015) 22, 549–559; doi:10.1038/cdd.2015.3; published online 6 February 2015
Since the publication of this article the authors have noted that they have inadvertently failed to list an important paper in the field in Table 2. This work (Kleber et al.) has now been added to the revised Table 2 shown below. The authors wish to apologize to these authors for the omission.
Additional information
The online version of the original article can be found at 10.1038/cdd.2015.3
Rights and permissions
About this article
Cite this article
Peter, M., Hadji, A., Murmann, A. et al. Erratum: The role of CD95 and CD95 ligand in cancer. Cell Death Differ 22, 885–886 (2015). https://doi.org/10.1038/cdd.2015.25
Published:
Issue date:
DOI: https://doi.org/10.1038/cdd.2015.25
This article is cited by
-
Ketoprofen suppresses triple negative breast cancer cell growth by inducing apoptosis and inhibiting autophagy
Molecular Biology Reports (2023)
-
The mechanism of how CD95/Fas activates the Type I IFN/STAT1 axis, driving cancer stemness in breast cancer
Scientific Reports (2020)
-
Candidate protein biomarkers in pancreatic neuroendocrine neoplasms grade 3
Scientific Reports (2020)
-
Engineering universal cells that evade immune detection
Nature Reviews Immunology (2019)
-
Magnetic nanoparticle-mediated gene therapy to induce Fas apoptosis pathway in breast cancer
Cancer Gene Therapy (2018)